Rob is an experienced C-level executive with 25 years in building technology focused businesses in the healthcare space. Rob has founded and transitioned several start-up companies most recently as CEO of clinical-stage QUE Oncology and as the inaugural CEO of ASX-listed cancer drug company Prescient Therapeutics. As former Head of Melbourne Operations for Arana Therapeutics, Rob played a key role in Arana’s successful A$318M acquisition by Cephalon Incorporated. Rob provides specialist advice to companies looking to turn smart innovation into commercial ventures.
Written by
The Marketing Co, Instructor
Share this article:
Commercialisation
The companies delivering the projects have achieved outstanding results in attracting private investment.
*as at 17 June 2022 and based on the exchange rate of $1 USD to $1.42AUD – From Pitchbook analysis of recipients announced up to May 2022
Information Sessions
Want to learn more about the program but don’t know where to start?
Join the team from i4 Connect to learn more about our service.
